The Searle Co (KAR:SEARL) Moat Score: 0/10 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:SEARL The Searle Co Ltd KAR:SEARL
73 GF Score
Price ₨92.30
GF Value ₨76.13
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is The Searle Co Moat Score?

The Searle Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

The Searle Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes The Searle Co might have No Moat - No discernible moat.

The Searle Co  (KAR:SEARL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

The Searle Co Moat Score Related Terms

KAR:SEARL
73GF Score
The Searle Co Ltd KAR:SEARL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is The Searle Co (KAR:SEARL) Overvalued in 2026?

Based on GuruFocus' analysis, The Searle Co stock appears to be overvalued. The current stock price of ₨92.30 is trading 21.2% above its estimated GF Value™ of ₨76.13. GuruFocus considers The Searle Co to be Modestly Overvalued.

Key valuation signals for KAR:SEARL:

  • Moat Score: 0
  • GF Value™: ₨76.13 vs. price of ₨92.30 (21.2% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the KAR:SEARL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Searle Co Business Description

Address Tipu Sultan Road, Block 7 and 8, Plot No. 1, One IBL Centre, 2nd Floor, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
The Searle Co Ltd is principally engaged in the manufacturing and sale of pharmaceutical, consumer health, and nutritional products. It manufactures and sells products such as Semavi, Dalimab, Extor, Tramal, Rotec, Hylixi, Emsyn, and many more, focusing on various therapeutic areas like cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care. Additionally, the group offers medical devices and disposables, health supplements, and various nutritional consumable products. The majority of the group's revenue consists of pharmaceutical sales. Geographically, it generates maximum revenue from Pakistan, and rest from Sri Lanka, Cambodia, Myanmar, Oman, Vietnam, and other countries.
73GF Score

Get the complete analysis for KAR:SEARL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨92.30
Price
₨76.13
GF Value